Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “cutaneous melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00005971
What this trial is testing

Flavopiridol in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Melanoma (Skin)
NCIC Clinical Trials Group 17
Testing effectiveness (Phase 2)Ended earlyNCT04337931
What this trial is testing

Evaluate Sotigalimab (APX005M) in Subjects With Unresectable or Metastatic Melanoma

Who this might be right for
Unresectable MelanomaMetastatic MelanomaCancer+3 more
Apexigen America, Inc. 45
Not applicableStudy completedNCT04593277
What this trial is testing

Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study

Who this might be right for
Clinical Stage I Cutaneous Melanoma AJCC v8Clinical Stage II Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Melanoma AJCC v8+13 more
Fred Hutchinson Cancer Center 549
Very early researchEnded earlyNCT03893019
What this trial is testing

MB-CART20.1 Melanoma

Who this might be right for
Melanoma (Skin)
Miltenyi Biomedicine GmbH 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT04291105
What this trial is testing

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

Who this might be right for
MelanomaHead and Neck Squamous Cell CarcinomaColo-rectal Cancer
Vyriad, Inc. 87
Testing effectiveness (Phase 2)Ended earlyNCT00612222
What this trial is testing

Anti-MART-1 F5 Cells Plus ALVAC MART-1 Vaccine to Treat Advanced Melanoma

Who this might be right for
Metastatic MelanomaSkin Cancer
National Cancer Institute (NCI) 4
Early research (Phase 1)Study completedNCT00375245
What this trial is testing

Rapamycin With Grapefruit Juice for Advanced Malignancies

Who this might be right for
TumorsNeoplasm Metastasis
University of Chicago 41
Not applicableActive Not RecruitingNCT07022457
What this trial is testing

UK ENcorafenib and BInimetinib Real-world Study in Melanoma

Who this might be right for
Metastatic Melanoma, BRAF V600 Mutation Positive
Pierre Fabre Ltd 50
Testing effectiveness (Phase 2)Looking for participantsNCT05655312
What this trial is testing

MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

Who this might be right for
Recurrent Melanoma (Skin)Metastatic MelanomaMelanoma Stage IV+1 more
Perspective Therapeutics 300
Testing effectiveness (Phase 2)Study completedNCT00243594
What this trial is testing

Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection

Who this might be right for
Melanoma Stage III or IV
Radboud University Medical Center 40
Testing effectiveness (Phase 2)UnknownNCT00086866
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery

Who this might be right for
Melanoma (Skin)
European Organisation for Research and Treatment of Cancer - EORTC 165
Not applicableStudy completedNCT03745872
What this trial is testing

SunSmart Intervention in Schools

Who this might be right for
Melanoma
University of Colorado, Denver 76
Testing effectiveness (Phase 2)Study completedNCT01743157
What this trial is testing

Biochemotherapy and Bevacizumab Followed by Consolidation Therapy With Ipilimumab for Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
California Pacific Medical Center Research Institute 24
Testing effectiveness (Phase 2)Study completedNCT00861913
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Metastatic Melanoma That Cannot be Removed by Surgery

Who this might be right for
Recurrent MelanomaStage IV Cutaneous Melanoma AJCC v6 and v7
National Cancer Institute (NCI) 13
Testing effectiveness (Phase 2)Study completedNCT03711188
What this trial is testing

IMM-101 in Combination With Checkpoint Inhibitor Therapy in Advanced Melanoma

Who this might be right for
Melanoma
Immodulon Therapeutics Ltd 16
Testing effectiveness (Phase 2)Ended earlyNCT01970527
What this trial is testing

Phase II Trial of Stereotactic Body Radiotherapy Followed by Ipilimumab in Treating Patients With Stage IV Melanoma

Who this might be right for
Recurrent MelanomaStage IV Skin Melanoma
University of Washington 23
Not applicableStudy completedNCT04577742
What this trial is testing

Uveal Melanoma and Brachytheraphy: Long-term Outcomes.

Who this might be right for
106 Ruthenium Plaque BrachytherapyUveal Melanoma
Federico II University 350
Not applicableUnknownNCT05426317
What this trial is testing

Exploratory Interventional Study of Prognostic Serum Biomarkers of Cancer Progression

Who this might be right for
MelanomaNon Small Cell Lung CancerRenal Cancer
University Hospital, Clermont-Ferrand 100
Large-scale testing (Phase 3)UnknownNCT00000124
What this trial is testing

Collaborative Ocular Melanoma Study (COMS)

Who this might be right for
Choroid NeoplasmsUveitis
National Eye Institute (NEI)
Not applicableEnded earlyNCT02439008
What this trial is testing

Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response

Who this might be right for
Carcinoma, HepatocellularColorectal NeoplasmsMelanoma+1 more
Centre Oscar Lambret 28
Next Page